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N-Glycosylation affects the function of ion channels at the
level of multisubunit assembly, protein trafﬁcking, ligand
binding and channel opening. Like the majority of mem-
brane proteins, ionotropic P2X receptors for extracellular
ATP are glycosylated in their extracellular moiety. Here,
we used site-directed mutagenesis to the four predicted N-
glycosylation sites of P2X3 receptor (Asn
139, Asn170,
Asn194 and Asn290) and performed comparative analysis
of the role of N-glycans on protein stability, plasma mem-
brane delivery, trimer formation and inward currents. We
have found that in transiently transfected HEK293 cells,
Asn170 is apparently the most important site for receptor
stability, since its mutation causes a primary loss in
protein content and indirect failure in membrane
expression, oligomeric association and inward current
responses. Even stronger effects are obtained when mutat-
ing Thr172 in the same glycosylation consensus. Asn194
and Asn290 are the most dispensable, since even their sim-
ultaneous mutation does not affect any tested receptor
feature. All double mutants containing Asn170 mutation or
the Asn139/Asn290 double mutant are instead almost
unable to assemble into a functional trimeric structure.
The main emerging ﬁnding is that the inability to assem-
ble into trimers might account for the impaired function
in P2X3 mutants where residue Asn
170 is replaced. These
results improve our knowledge about the role of N-glyco-
sylation in proper folding and oligomeric association of
P2X3 receptor.
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Introduction
It is well known that N-glycosylation often affects the func-
tion of ion channels at the level of multisubunit assembly,
protein trafﬁcking, ligand binding and channel opening
(Gehle et al. 1997; Standley and Baudry 2000; de Souza and
Simon 2002; Gong et al. 2002; Watanabe et al. 2003).
N-Linked glycans also exert a well-recognized role as matu-
ration and quality-control tags in the early secretory pathway
(Hebert et al. 2005). They are added co-translationally during
the translocation in the lumen of the endoplasmic reticulum
(ER; Kowarik et al. 2002) and mediate the recognition by the
lectin chaperones, calnexin and calreticulin, which assist
proper protein folding (Molinari and Helenius 2000; Daniels
et al. 2003). The overall importance of glycosylation in mem-
brane and secretory proteins has been further revealed by con-
genital disorders of glycosylation, which are multisystem
syndromes causing various degrees of mental and psychomo-
tor retardation and severely affecting humans (Freeze 2001;
Jaeken and Carchon 2004).
P2X receptors constitute a family of seven (P2X1–7) cation
channels gated by extracellular ATP. They are expressed in
many excitable and not excitable cells to mediate a variety of
physiological actions, including smooth muscle contraction,
neuroendocrine secretion and synaptic transmission (Khakh
and North 2006). They have a membrane topology with two
transmembrane domains and form functional homo- or hetero-
trimeric channels on the plasma membrane (PM; Nicke et al.
1998; Barrera et al. 2005). Among them, the P2X3 subtype
that we demonstrated to be enriched in specialized submem-
brane compartments such as lipid rafts (Vacca et al. 2004) is
present in cell bodies as well as in peripheral and central term-
inals of sensory neurons of dorsal root ganglia (Vulchanova
et al. 1997), where it performs a well-deﬁned role in sensory
and pain transmission (Cockayne et al. 2000; Souslova et al.
2000; North 2004). Like the majority of membrane proteins,
all P2X receptors are glycosylated in their extracellular moiety.
N-Glycosylation has been studied in several members of the
P2X family: Asn-linked glycans in P2X1 (Rettinger et al.
2000; Roberts and Evans 2006), P2X2 (Torres et al. 1998),
P2X4 (Hu et al. 2002) and P2X6 (Jones et al. 2004) receptor
subtypes have been shown to affect several aspects of receptor
function, including oligomerization, surface expression and
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channel function. Whereas the four consensus sequences
(N-X-S/T) for N-linked glycosylation in the extracellular
domain of P2X3 receptor (Asn
139, Asn170, Asn194 and Asn290)
are homologous to the four recognized N-glycosylation sites of
P2X1 receptor (Rettinger et al. 2000), there is only a partial
homology with the number and position of N-glycans in all
other P2X isoforms.
In a previous study, we demonstrated that P2X3 receptor
undergoes rapid constitutive endocytosis accompanied by pre-
ferential targeting to late endosomes/lysosomes with sub-
sequent degradation (Vacca et al. 2009). In the present work,
we used site-directed mutagenesis to investigate the role of
N-glycans in P2X3 receptor function. By means of transiently
transfected HEK293 cells, we demonstrated an essential but
heterogeneous role of N-glycan residues in overall protein
expression, PM delivery, oligomerization and inward current
response.
Results
Effect of single N-glycosylation site mutation on functional
expression of P2X3 receptor
In order to evaluate how the removal of individual
N-glycans affects the functional expression of P2X3 recep-
tor, we produced N-glycosylation defective mutants by sub-
stituting Asn with Gln through site-directed mutagenesis in
the four predicted N-glycosylation sites of the receptor
(Asn139, Asn170, Asn194 and Asn290). Sequence alignment
of P2X3 with the other P2X family members shows a
different degree of conservation among these glycosylation
sites, with Asn139 and Asn170 being the more conserved
(ﬁve and six P2X members, respectively; Figure 1).
Remarkably, no single N-glycosylation consensus is con-
served within the seven members of the family. Wild-type
(WT) and mutated receptors were transiently transfected in
HEK293 cells, since this cell line has been previously and
successfully used to characterize the properties of P2X3, as
well as of other P2X ion channels (Surprenant et al. 2000;
Fischer et al. 2003; Jones et al. 2004). We recorded inward
current responses at −40 mV, using 100 μM α,β-methylene
ATP (αβmeATP) as a ligand. At this concentration, we
obtained maximal current responses from WT P2X3 recep-
tor. The currents recorded from the single-mutated N139Q,
N194Q and N290Q receptors were found quantitatively
identical to those of WT, indicating that none of these
three glycans was essential for functional expression.
Conversely, N170Q mutated receptor exhibited a consist-
ently lower response (60% reduction; Figure 2A, Table I).
In order to evaluate if this reduced current was due to
altered function or to reduced PM delivery, we measured
the expression of WT and mutated receptors at the PM. We
performed cell-surface biotinylation of PM proteins using
the cell-impermeant reagent Biotin-XX-SE. As shown in
Figure 2B and Table I, total and PM expression of mutated
receptors resembled what we also observed with inward
current measurement: N139Q, N194Q and N290Q single
N-glycan mutants displayed a level of PM expression
similar to WT receptors. N170Q mutant instead exhibited a
consistent reduction in both total and PM expression, as
well as in inward current (Figure 2A). The percent of PM
receptor vs. total protein is relatively low (15%) for P2X3
receptor due to constitutive endocytosis (Vacca et al., 2009)
and is not further decreased in the N170Q mutant com-
pared with control (Figure 2D). These observations suggest
that the receptors that do not reach the PM are not accumu-
lating intracellularly and are probably degraded. Since it
has been already observed that different mutations in the
N-glycosylation consensus (N-X-S/T) can produce different
functional effect independently from the effect on glycosy-
lation (Gong et al. 2002), we also mutated Thr172 to Ala in
the Asn170 consensus. Gel analysis (×Figure 2C; Figure 3)
conﬁrmed that T172A mutant failed to be glycosylated just
as N170Q. The effect of T172A mutation appeared drasti-
cally more severe, with respect to N170Q, on both total
and PM expression (Figure 2C), as well as on current
responses (Figures 2A). As for N170Q, the PM/total
protein ration is not signiﬁcatively altered for the T172A
mutant (Figure 2D).
In order to conﬁrm that each individual consensus site is
indeed N-glycosylated, we performed complete deglycosyla-
tion of protein extracts with N-Glycosidase F (PNGase F). As
Fig. 1. Alignment of the extracellular portion of rat P2X-family receptors
protein sequences. Protein sequences of P2X1–7 from rat origin were obtained
from UniprotKB database (accession numbers: P47824 (P2X1), P49653
(P2X2), P49654 (P2X3), P51577 (P2X4), P51578 (P2X5), P51579 (P2X6) and
Q64663 (P2X7)) and aligned with ClustalW2 software. Consensus sequences
for N-glycosylation are highlighted in grey. N-Glycosylation sites of P2X3
(N139, N170, N194 and N290) are indicated.
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shown in Figure 3, all mutants showed the same electrophor-
etic mobility of WT receptor after PNGase F treatment,
indicating that the increased mobility observed in mutants
before treatment was due to differential glycosylation status,
and not to aberrant effects of amino-acid substitution. Even
after extensive PNGase F treatment, P2X3 receptor clearly
migrated as a triplet, indicating that this heterogeneity likely
depends on post-translational modiﬁcations different from
N-glycosylation.
The effect of double mutation is strongly dependent on the
identity of the mutated N-glycan
Differently from single mutants, the majority of double
mutations strongly affected receptor expression on its
whole and at the PM (Figure 4B). Moreover, as shown in
Figure 4A and Table I, N139Q/N170Q, N139Q/N290Q,
N170Q/N194Q and N170Q/N290Q mutants elicited very low
or null inward currents when stimulated with αβmeATP.
Conversely, N139Q/N194Q mutant elicited a considerable,
although lower than WT, inward current response (60%
reduction). Only N194Q/N290Q mutant held an inward
current indistinguishable from the WT receptor. Similarly to
what observed with single mutants, also in double-mutant
receptors, there was always a correspondence between current
and protein expression levels (Figure 4A and B, Table I).
Nevertheless, for those double mutants displaying very low
current responses (N139Q/N170Q, N139Q/N290Q, N170Q/
N194Q and N170Q/N290Q), a concomitant impairment in ion
channel responsiveness cannot be excluded.
EC50 is also affected in N170Q and N139Q/N194Q mutants
The single-mutant N170Q and the double-mutant N139Q/
N194Q showed a clear reduction in inward current compared
with the WT receptor (40% at 100 µM αβmeATP) that can
be mostly attributed to reduced the PM expression of the
mutant. In order to better analyze the effect of mutation on
channel function, we performed a full dose response on these
mutants. As shown in Figure 5, not only Imax was signiﬁ-
cantly decreased, but also EC50 of mutants was clearly
increased in both mutants, compared with WT (75%),
Fig. 2. Effect of single mutation of N-glycosylation sites on functional expression of P2X3 receptor. (A) Inward currents induced by 100 μM αβmeATP on WT
and N-glycosylation site-mutated P2X3 receptor transfected in HEK293 cells. Data represent an average of at least 10 cells recorded for each mutant from three
independent transfections. *P < 0.05 in Student’s t-test compared with WT. (B and C) HEK293 cells, transfected with the indicated mutants, were labeled with
the Biotin-XX-SE. Streptavidin precipitated (PM P2X3) and total cell extracts (Total P2X3) were probed with P2X3 antiserum in western blot. The neomycin PT
II protein was used to normalize plasmid expression levels. Similar results were obtained in at least three independent experiments. (D) Percent streptavidine
precipitated. P2X3 (PM) vs. the amounts of P2X3 in the starting cell lysate for WT and indicated mutant receptors.
Table I. Synoptic view of the effects of single or double mutations of
N-glycosylation sites of P2X3 receptor on total protein content, PM
expression, percent of receptor present in the trimeric form and inward current
Tot Prot PM Trimer (%) Current
WT 100 100 81 ± 7 100
N139Q 92 ± 17 85 ± 18 75 ± 17 102 ± 35
N170Q 43 ± 15 55 ± 11 62 ± 11 40.5 ± 5
T172A 28 ± 13 38 ± 7 – 20.5 ± 3
N194Q 85 ± 17 87 ± 13 75 ± 16 101 ± 32
N290Q 89 ± 14 84 ± 15 79 ± 15 102 ± 30
N139Q/N170Q 34 ± 13 23 ± 6 18 ± 5 5 ± 4
N139Q/N194Q 45 ± 9 55 ± 8 72 ± 9 39 ± 20
N139Q/N290Q 28 ± 12 31 ± 12 18 ± 4 0 ± 0
N170Q/N194Q 26 ± 8 14 ± 6 15 ± 6 5.2 ± 3
N170Q/N290Q 20 ± 8 13 ± 5 19 ± 3 3 ± 2
N194Q/N290Q 95 ± 10 102 ± 12 80 ± 5 93.5 ± 29
Data represent the % values ± SD, referred to the control WT P2X3 receptor
(100%) for total protein, PM expression and inward current. Total and PM
protein levels were normalized to Neomycin PT II protein levels. These data
are the average of at least three independent experiments (western blots) or at
least 10 cells recorded for each mutant from three independent transfections,
*P < 0.05 in Student’s t-test.
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indicating that the mutations generated also a defect in ligand
afﬁnity and not only in trafﬁcking of the receptor.
Nonfunctional-mutated receptors do not form appreciable
levels of trimers
Blue native (BN) gel electrophoresis was performed in order
to evaluate the ability of N-glycan mutants of P2X3 receptor
to form trimers, the functional oligomer for this receptor
subtype. Whereas all single mutants were mainly detected in
their trimeric form, the amount of trimer was strongly reduced
in the N170Q mutant, consistently with reduced content of
total and PM receptor protein (Figure 6, Table I). Also the
functional N-glycan double mutants N139Q/N194Q and
N194Q/N290Q were expressed as trimers, whereas the four
not functional double mutants N139Q/N170Q, N139Q/
N290Q, N170Q/N194Q and N170Q/N290Q were instead
detected mainly as dimers and monomers. This result would
indicate that deﬁciency in trimeric formation might be caused
not only by the overall reduced expression of mutated P2X3
protein, but also by the direct inability of N-glycan double
mutants to correctly oligomerize.
Inhibition of 26S proteasome rescues the content of mutated
receptors but not the trimer formation
The role of N-glycans in the proper folding and 26S
proteasome-dependent degradation of glycoproteins is well
documented (Meusser et al. 2005). We thus hypothesized that
the reduced level of expression of selected double glycosyla-
tion mutants might be due to improper folding and conse-
quent degradation of the mutated receptors. After treating the
cells with the 26S proteasome inhibitor MG132 for 7 h, we
observed that total and PM protein levels consistently
increased in all double-mutated receptors (Figure 7).
Moreover, especially in MG132-treated cells, we observed the
accumulation of a P2X3 immunoreactive band of 75–80 kDa,
likely corresponding to the poly-ubiquitinated form of the
receptor, as recognized by anti-ubiquitine antibodies (data not
shown). The same band was moreover abolished performing
Fig. 3. Effect of deglycosylation with PNGase F on P2X3 receptor mutants gel motility. Cell extracts from HEK293 cells were treated with or without PNGase F
(1 U/100 mg of proteins) for 18 h at 37°C and probed with P2X3 antiserum in western blot.
Fig. 4. Effect of double mutation of N-glycosylation sites on functional expression of P2X3 receptor. (A) Inward currents induced by 100 μM αβmeATP on WT
and N-glycosylation site-mutated P2X3 receptor transfected in HEK293 cells. Data represent an average of at least 10 cells recorded for each mutant from three
independent transfections. *P < 0.05 in Student’s t-test compared with WT; **P < 0.05 in Student’s t-test compared with N139Q/N194Q. (B) HEK293 cells,
transfected with the indicated mutants, were labeled with the Biotin-XX-SE. Streptavidin precipitated (PM P2X3) and total cell extracts (Total P2X3) were probed
with P2X3 antiserum in western blot. The neomycin PT II protein was used to normalize plasmid expression levels. Similar results were obtained in at least three
independent experiments.
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immunoreactions in the presence of the P2X3 receptor speciﬁc
immunogenic peptide (data not shown). The 75–80 kDa band
was also highly reduced from PM fractions (Figure 7),
therefore indicating that ubiquitination of the receptor was
scarcely compatible with recruiting at the PM. Finally, treat-
ment with MG132 increased oligomerization mainly in WT,
Fig. 6. Oligomeric structure of N-glycosylation site-mutated P2X3 receptor. HEK293 were transiently transfected with WT and the indicated mutant P2X3
receptors. Cell extracts were analyzed by BN gel electrophoresis in order to analyze the oligomeric structure of the receptor. Similar results were obtained in at
least three independent experiments.
Fig. 5. Concentration-response curves of αβmeATP (0.03–3000 µM) in HEK293 cells transfected with the WT P2X3 receptor (WT) and with its mutants
(N170Q, N139/N194Q and T172A). αβmeATP was pressure applied for 2 s in the close proximity to the recorded cell. Data are reported as the mean ± SEM
(n = 4–16 cells for each agonist concentration) and are ﬁtted using the Hill equation (see Materials and Methods for details). For T172A mutant, we did not
calculate the response current at 3000 µM concentration because 100 and 300 µM αβmeATP already produced the maximal response. (B) Synoptic view of the
effects of single and double mutations of N-glycosylation sites of P2X3 receptor on EC50, Imax and Hill coefﬁcient. Data are reported as the mean ± SEM. *P <
0.05 relative to WT in unpaired Student’s t-test.
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N194Q/N290Q and N139Q/N194Q receptors, the only
mutants to be already present as trimers under basal con-
ditions (Figure 8). Those double mutants totally unable to tri-
merize (N139Q/N170Q, N139Q/N290Q, N170Q/N194Q and
N170Q/N290Q) instead failed to assemble in oligomeric
structures, even in the presence of MG132, but formed a
remarkably high molecular weight smeared protein complex,
likely corresponding to multi-aggregated forms of the receptor
also protected from degradation.
Discussion
The results presented in this work provide direct evidence
about the role of N-glycosylation in some different steps that
lead to the functional expression of P2X3 receptor on the cell
surface. We demonstrated that the predicted glycosylation
sites Asn139, Asn170, Asn194 and Asn290, which are homolo-
gous to the established glycosylated sites of P2X1 receptor
(Rettinger et al. 2000), are indeed glycosylated in vivo, as
revealed by the shift in molecular weight observed in every
single mutant. Nonetheless, a diverse degree of stringency
pertains to the different N-glycan residues toward overall
protein stability, PM delivery, trimer formation and inward
current response. The three N-glycosylation residues Asn139,
Asn194 and Asn290 are apparently dispensable for functional
expression of P2X3 protein (single mutations still allowed
maximal inward current and proper trimeric folding), although
our analysis cannot exclude that fully responsive mutated
receptors could still elicit less obvious changes in biochemical
or electrophysiological properties. Instead, N-glycosylation
residue Asn170 is found necessary for full overall and PM
receptor expression, proper oligomerization and current
response. The increase in EC50 compared with WT clearly
indicates a reduced ligand afﬁnity of the N170Q mutant. On
the other hand, the reduction in Imax (62 % of WT,
Figure 5) correlates well with that in PM expression (55 ±
11%, Table I), indicating that the mutant receptors reaching
the PM are likely functional.
However, Asn170 is not the only essential glycosylation
residue, since also double mutation of Asn139 and Asn290 resi-
dues caused complete improper folding and functional loss.
Contemporary mutation of either combination of three glyco-
sylation sites or treatment of cells with tunicamycin comple-
tely impairs the PM expression of the receptor (not shown)
indicating that a certain degree of glycosylation is necessary
for receptor functional assembly.
High-resolution crystal structure of the zebraﬁsh P2X4.1
receptor has been recently solved (Kawate et al. 2009). Of the
four glycosylation sites of the rat P2X3 receptor, Asn
139 and
Asn290 are not conserved in zebraﬁsh P2X4.1, Asn
194 is not
strictly conserved but a new consensus is present and shifted
by only two amino acids, whereas Asn170 is conserved. When
superimposing the rat P2X3 sequence to the P2X4 structure,
all four glycosylated asparagines lie in exposed regions of the
molecule. Interestingly, the homologous of Asn170 (Asn187 in
P2X4) is placed very near to the cavity proposed to bind ATP
with Thr of the consensus site (Thr189 in P2X4) directly
taking part in nucleotide binding. This observation could
explain the stronger effect of Asn170 mutation on P2X3 recep-
tor function compared with the other glycosylation mutants
and also the more dramatic effect of the Thr172 mutation
(homologous to Thr189 in P2X4) with respect to Asn
170.
Differently from the N170Q mutant, the reduction in the Imax
of the T172A mutant (18% of WT, Figure 5) is signiﬁcantly
more severe than that in PM expression (38 ± 7%, Table I),
thus suggesting also a partial functional impairment of the
receptor pool reaching the PM. Functional impairments have
been indeed already observed when mutating the homologous
Thr in P2X1 (Roberts and Evans 2006) and P2X2 (Jiang et al.
2000) receptors. Moreover, the homologous of Asn170 is also
critical for PM trafﬁcking and function of P2X7 receptor
(Lenertz et al. 2010).
Our data also conﬁrm the results obtained by a similar
analysis of N-glycan mutations on the functional expression
Fig. 7. Role of 26S proteasome inhibition on overall and PM expression of
N-glycosylation site-mutated P2X3 receptor. HEK293 were transiently
transfected with WT and the indicated mutant P2X3 receptors. Cells were
treated in the presence (+) or the absence (−) of 5 μM MG132 for 7 h, and
protein extracts were analyzed by SDS–PAGE–western blot for total and PM
P2X3 receptor protein. Similar results were obtained in at least three
independent experiments.
Fig. 8. Role of 26S proteasome inhibition on oligomerization of
N-glycosylation site-mutated P2X3 receptor. HEK293 cells were transiently
transfected with WT and the indicated mutant P2X3 receptors. Cells were
treated in the presence (+) or the absence (−) of 5 μM MG132 for 7 h. Cell
extracts were analyzed by BN gel electrophoresis in order to analyze
oligomeric structure of the receptors. Similar results were obtained in at least
three independent experiments.
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of P2X1 protein (Rettinger et al. 2000). Yet, the effects that
we observed with P2X3 receptor were consistently more pro-
nounced, especially in the case of the double mutants, and the
residue Asn184 in the P2X1 receptor (homologous to Asn
170
in P2X3) seemed to be less critical (Rettinger et al. 2000),
therefore signifying that the P2X3 receptor subtype is prob-
ably more dependent than P2X1 upon N-glycans for proper
assembly, trafﬁcking and function. This diversity might also
be due to variation in the cell systems and species adopted,
since the work on P2X1 was performed in Xenopus oocytes.
Indeed, in the same HEK293 cellular system, the importance
of N-glycans for proper functioning of P2X3 receptors was
already recognized, since only fully N-glycosylated receptors
responded to external pH with a modiﬁed sensitivity toward
αβmeATP, and the absence of individual N-glycans modiﬁed
the pH sensitivity, most probably by an allosteric mechanism
(Wirkner et al. 2008). Again in HEK293 cells, N-glycan
double-mutation studies performed on P2X2 (Torres et al.
1998) provided more similar results to ours on P2X3.
Although in the absence of systematic mutagenesis of all indi-
vidual N-glycosylation sites, studies carried out on P2X4 (Hu
et al. 2002) and P2X6 (Jones et al. 2004) receptors again con-
ﬁrmed our results indicating the crucial role of N-glycans in
the full functional expression of this entire family of ionotro-
pic receptors.
It is well known that misfolded proteins are eliminated by a
process called ER-associated degradation. Basically, proteins
are back translocated from ER into the cytosol and then
degraded by the 26S proteasome (Meusser et al. 2005). P2X
receptors are well known to be present as trimers in the ER,
meaning that they assemble in trimeric structures early in the
biosynthetic pathway (Nicke et al. 1998). The relationship
between oligomerization and degradation is nevertheless still
unclear. With our studies, we recognized that inhibition of the
26S proteasome leads to accumulation of both WT and all
double-mutated receptors and that total content of whole and
PM P2X3 receptor is comparable in WT vs. double mutants
in the presence of proteasome inhibitor. These results indi-
cated that the observed low levels of mutant proteins were
probably due to proteasome-dependent degradation. This was
also conﬁrmed by the ubiquitous presence (signiﬁcantly not at
the PM) of a 75–80 kDa poly-ubiquitinated P2X3 protein
signal. It is not clear yet to what extent the various sequential
steps of the degradation process are linked to one another
(Elkabetz et al. 2004). Major histocompatibility complex class
I and T-cell receptors are known to accumulate in the cytosol
when proteasomal degradation is inhibited (Wiertz et al.
1996; Yu et al. 1997). Instead, for other proteins such as the
immunoglobulin moieties, dislocation and proteasomal func-
tion appear to be strictly linked, since it has been observed
that proteasomal blockade can cause the retention of these
proteins in the ER membrane (Chillaron and Haas 2000;
Mancini et al. 2000). After proteasomal inhibition, the con-
sistent increase in all mutated P2X3 proteins reaching the PM
therefore indicates not only that mutated receptors are pro-
tected from back translocation to the cytosol, but also that
mutated P2X3 receptors can progress through the entire
secretory pathway. Conversely, when we looked at oligomeri-
zation of WT vs. mutated receptors, we found that inhibition
of the 26S proteasome increases the trimeric form of the
receptor, when this is less abundant (N139Q/N194Q), while
having a moderate effect on WT and N194Q/N290Q mutant.
In the other mutated receptors (N139Q/Asn170, N139Q/
N290Q, N170Q/N194Q and N170Q/N290Q) in which the
trimers were barely detectable under basal conditions, these
are not present also after 26S proteasome inhibition, indicat-
ing that these mutants are likely not competent for trimer for-
mation. This would signify that complete trimerization is
prevented by early degradation in the N139Q/N194Q mutant
even if this mutant is still competent for trimerization. This is
also conﬁrmed by the observation that, even in the presence
of lower levels of protein, the percent of receptor present in
the trimeric form is only slightly lower than WT for both
N170Q and N139Q/N194Q mutants.
In synthesis, we demonstrated here that the six different
possible combinations of N-glycan double mutants of P2X3
protein differently inﬂuence oligomerization and functional
expression of the receptor and induce various extents of
receptor degradation. By comparative analysis, we moreover
established a diverse degree of stringency in the different
N-glycans, with Asn170 that appears to be the most important
site for receptor proper folding and stability, since its single or
joint mutation caused the most severe impairments.
Consistently, this is the best conserved glycosylation site
within the P2X family and the recently solved crystal structure
of P2X4 places this residue very close to the putative ATP
binding site (Kawate et al. 2009). Asn194 and Asn290 were
instead the most dispensable, as their simultaneous mutation
did not apparently affect any receptor feature. All remaining
double mutants elicited progressively more severe impair-
ments. When proteasomal degradation was instead inhibited,
whereas full receptor stability and trafﬁcking to the PM was
restored for all the combinations of N-glycan double mutants,
trimerization was only selectively permitted, therefore indicat-
ing that folding impairments cannot be overcome by receptor
stabilization.
In conclusion, these results improve our knowledge about
the role of N-glycosylation in proper folding and oligomeric
association of P2X3 receptor. A new emerging ﬁnding is that
the inability to assemble into trimers might account for the
impaired function in mutants where residue Asn170 is
replaced. This might shed light on a novel mechanism even-
tually responsible for malfunctioning of this receptor during
pathological conditions.
Materials and methods
Cell cultures, transfections and treatments
The human HEK293 cell line was cultured in Dulbecco’s
modiﬁed Eagle’s medium (Sigma, Milano, IT), supplemented
with 2 mM L-glutamine, 100 U/mL of penicillin, 100 μg/mL
of streptomycin and 10% heat inactivated calf serum
(Invitrogen, San Giuliano Milanese, Italy). Cells were trans-
fected with full-length cDNA coding for P2X3 WT and
mutated receptors inserted in the pcDNA3 vector (Invitrogen);
control cells were transfected with the empty pcDNA3 vector.
Cells were transfected at 80–90% conﬂuence in 35 mm wells
with 5 µL of lipofectamine 2000 reagent (Invitrogen) and
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4 μg of plasmid DNA, according to the manufacturer’s
instructions. The medium was replaced after 4 h and exper-
iments were performed 24 h later. Similar results were
obtained when experiments were performed 48 h after trans-
fection even if the expression level was already slightly
declining compared with 24 h.
Site-directed mutagenesis
Asn-coding triplets in the four N-glycosylation consensus
sequences in the rat P2X3 cDNA were substituted with
Gln-coding triplets by two-step overlapping polymerase chain
reaction site-directed mutagenesis, essentially as described
(Ho et al. 1989).
The following primers were used for the mutations: N139Q
(for-GGCCGCTGCGTGCAATACAGCTCTGTT; rev-CCGG
AGAACAGAGCTGTATTG CACGCA); N170Q (for-CATGA
TGGAGGCTGAGCAATTCACCAT; rev-TGATGAAA ATGG
TGAATTGCTCAGCCT); N194Q (for-GGGAAACCTCCTG
CCTCAACTCACCGA; rev-CTTGTCGGTGAGTTGAGGCA
GGAGGTT); N290Q (rev-CTATAAGATGGAGCAAGGCA
GCGAGTA; rev-TACTCGCTGCCTTGCTCCATCTTATAG)
and T172A (for-GGAGGCTGAGAACTTCGCCATTTTCA
TCAAGAAC; rev-GTTCTTGATGAAAATGGCGAAGTTC
TCAGCCTCC). Double mutants were produced introducing a
second mutation on a previously obtained single-mutated tem-
plate. All mutations and the lack of secondary mutation even-
tually introduced in the ampliﬁcation steps were veriﬁed by
sequencing on both strands.
Electrophysiological recordings
For electrophysiological experiments, HEK293 cells were
plated on glass coverslips and cotransfected with P2X3
plasmid and a green ﬂuorescent protein (GFP) expressing
plasmid (Invitrogen; 1:8 molar ratio). Coverslips were placed
in a recording chamber, on the stage of an upright microscope
(Axioscope FS, Carl Zeiss, Germany) equipped for infrared
video microscopy (Hamamatsu, Hamamatsu City, Japan) and
submerged in a continuously ﬂowing (2.5 mL/min) solution at
room temperature (20–22°C). This solution contained (in
mM) 126 NaCl, 2.5 KCl, 1.2 MgCl2, 1.2 NaH2PO4, 2.4
CaCl2, 10 glucose and 18 NaHCO3, gassed with 95% O2 and
5% CO2. Whole-cell patch clamp recordings were obtained
from GFP positive cells visualized by epiﬂuorescence at 480
± 40 nm excitation wavelength at an holding potential of −40
mV. Borosilicate glass electrodes (WPI 1.5 mm) were pulled
with a PP 83 Narishige puller. The resistance of the pipette
was 4 MΩ when ﬁlled with a standard solution
containing (in mM) 145 KCl-gluconate, 0.1 CaCl2, 2 MgCl2,
10 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid, 0.75
[Ethylenebis(oxyethylenenitrilo)]tetraacetic acid, 2 Mg-ATP,
and 0.3 Na3GTP, pH 7.3. The membrane voltage and current
were acquired using pClamp and Axoscope software (Axon
Instruments, Sunnyvale, CA). Agonist (100 μM αβmeATP)
was applied via a patch pipette that was positioned in close
vicinity of the cell body and was connected to a pressure
application system (Picospritzer, 20–30 psi, 0.1–10 s).
Concentration response curves of αβmeATP (0.03–
3000 μM) were obtained by pressure application of each
agonist concentration to a group of 4–16 cells. Data were
ﬁtted using the Hill equation:
I ¼ Imax
1þ ðEC50=xÞn
where I is the peak current produced by the agonist, Imax the
maximal current at saturating agonist concentration, n the Hill
coefﬁcient and EC50 the concentration of the agonist produ-
cing 50% of Imax.
Surface biotinylation and isolation of biotinylated proteins
After transfection (24 h), HEK293 cells were washed twice
with Dulbecco’s modiﬁed phosphate-buffered saline (D-PBS)
containing 0.6 mM MgCl2 and 1.8 mM CaCl2. Surface pro-
teins were biotinylated incubating the cells with 0.5 mg/mL of
6-((6-((biotynoyl)amino)hexanoyl)amino)-hexanoic acid, suc-
cinimidyl ester (Biotin-XX-SE) (Invitrogen) dissolved in
D-PBS containing 0.6 mM MgCl2 and 1.8 mM CaCl2 for 30
min at 4°C. Cells were then washed three times with D-PBS
and lysed with lysis buffer (10 mM Tris–HCl, pH 7.5, 150
mM NaCl, 1% Triton X-100, 2 mM ethylenediaminetetraace-
tate, 1 mM phenylmethylsulfonyl ﬂuoride, 20 μM leupeptin)
and centrifuged at 15000 × g for 10 min at 4°C. Cell lysates
were quantiﬁed for protein content by the Bradford method
(Bio-Rad Laboratories, Segrate, Italy) and normalized lysate
volumes were used. Biotinylated proteins were precipitated by
incubating lysates with streptavidin-coupled agarose beads
(Invitrogen) for 2 h at 4°C. Beads were then washed three
times with lysis buffer and then boiled for 5 min after the
addition of 2× Laemmli sample buffer (15 µL/sample).
Proteins were separated on sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE).
Protein deglycosylation with PNGase F
For PNGase F studies, total cell lysates (100 µg/condition)
were adjusted to a ﬁnal concentration of 0.2% SDS and 1%
β-mercaptoethanol, treated 10 min at 95°C and incubated 18 h
at 37°C, with or without 1 U of PNGase F (Roche
Diagnostics, Mannheim, Germany). Proteins were then separ-
ated on SDS–PAGE.
SDS–PAGE and BN–PAGE electrophoresis and
immunoblotting
For SDS–PAGE, cellular lysates were diluted in 4× Laemmli
sample buffer, containing a ﬁnal concentration of 2% (vol/
vol) β-mercaptoethanol as reducing agent, and proteins were
separated on 7.5 or 12.5% polyacrylamide gels. For BN gels,
cells were lysed in BN-lysis buffer (50 mM Bis–Tris, pH 7,
1% N-dodecyl maltoside, 10% glycerol, 0.75 M aminocaproic
acid). Cellular lysates were kept on ice for 30 min and then
centrifuged for 10 min at 14000 × g at 4°C. Supernatants were
collected and quantiﬁed. BN–PAGE was carried out essen-
tially as described (Schagger and Jagow 1991). After incu-
bation for 1 h at 37°C with 0.1% SDS, proteins were run on
8–14% gradient gels. Blotting to nitrocellulose membranes
(Amersham Biosciences, Milano, Italy) was performed using
Tris–glycine transfer buffer with 20% (vol/vol) CH3OH. Not
speciﬁc binding was prevented by incubating the blotted
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membranes in 5% (wt/vol) not fat dry milk in TBS-T (tris-
buffered saline, 0.2% (vol/vol) Tween-20). Primary antibodies
were incubated for 2 h at room temperature (neomycin phos-
photransferase II, 1:1000, purchased from Upstate, Billerica,
MA) or overnight at 4°C (P2X3, purchased from Alomone,
Jerusalem, Israel). Secondary peroxidase–conjugated anti-
bodies were used for 50 min at room temperature. The anti-
bodies were diluted in TBS-T with 3% (wt/vol) not fat dry
milk. Immunostained bands were visualized using the ECL
detection system (Amersham Biosciences) acquired with
Kodak 440CF Image Station; band intensities were measured
with 1D image analysis software (Eastman Kodak Company,
Rochester, NY). PM to total ratios of WT and mutant P2X3
receptors were estimated by comparing scalar amounts of
starting cell lysate with streptavidine precipitate as described
previously (Vacca et al. 2009).
Statistical analysis
Numerical data in bar graphs and table are expressed as the
mean ± SD. Unpaired Student’s t-test was used to compare
data and P < 0.05 was considered signiﬁcant.
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